Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, November 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 125 Dimensions

Readers on

mendeley: 179 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

Application WO-2023008461-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.